Hypermarcas (OTCMKTS:HYPMY) Shares Gap Down - What's Next?

Key Points

• Hypermarcas shares gapped down before trading, opening at $4.45 compared to the previous close of $4.87, and last traded at $4.44, indicating a decline of 5.1%.
• Scotiabank recently upgraded Hypermarcas stock to a "strong-buy" rating, potentially signaling positive future expectations despite the current price drop.
• The company reported a net margin of 12.51% with revenue of $184.34 million in the latest quarter, although it posted a loss of ($0.04) EPS.
• Hypermarcas has declared a dividend of $0.0345, with a yield of 2.81%, payable on January 8th, highlighting its commitment to returning value to shareholders.

Shares of Hypermarcas (OTCMKTS:HYPMY - Get Free Report) gapped down before the market opened on Friday . The stock had previously closed at $4.87, but opened at $4.45. Hypermarcas shares last traded at $4.44, with a volume of 847 shares trading hands.

Analyst Upgrades and Downgrades

Separately, Scotiabank raised Hypermarcas to a "strong-buy" rating in a research report on Thursday, July 17th.

Hypermarcas Trading Up 0.9%

The stock has a fifty day moving average of $4.72 and a 200 day moving average of $3.89. The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.80 and a current ratio of 1.26. The company has a market capitalization of $2.97 billion, a PE ratio of 19.54 and a beta of 0.81.

Hypermarcas Announces Dividend

The company also recently disclosed a dividend, which will be paid on Friday, January 8th. Shareholders of record on Tuesday, July 1st will be paid a $0.0345 dividend. This represents a yield of 2.81%. The ex-dividend date of this dividend is Monday, June 30th. Hypermarcas's payout ratio is 58.33%.

Hypermarcas Company Profile

Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.